# Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project

> **NCT00661154** · — · COMPLETED · sponsor: **Stanford University** · enrollment: 7 (actual)

## Conditions studied

- Colorectal Neoplasms
- Colon Cancer
- Rectal Cancer
- Anal Cancer

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT00661154
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-07
- **Final completion:** 2010-07
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2012-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00661154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00661154, "Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00661154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*